Tramadol

Generic Name
Tramadol
Brand Names
Conzip, Durela, Qdolo, Ralivia, Ryzolt, Seglentis, Tridural, Ultracet, Ultram, Zytram
Drug Type
Small Molecule
Chemical Formula
C16H25NO2
CAS Number
27203-92-5
Unique Ingredient Identifier
39J1LGJ30J
Background

Tramadol is a centrally acting synthetic opioid analgesic and SNRI (serotonin/norepinephrine reuptake-inhibitor) that is structurally related to codeine and morphine. Due to its good tolerability profile and multimodal mechanism of action, tramadol is generally considered a lower-risk opioid option for the treatment of moderate to severe pain. It is considered a Step 2 option on the World Health Organization's pain ladder and has about 1/10th of the potency of morphine.

Tramadol differs from other traditional opioid medications in that it doesn't just act as a μ-opioid agonist, but also affects monoamines by modulating the effects of neurotransmitters involved in the modulation of pain such as serotonin and norepinpehrine which activate descending pain inhibitory pathways. Tramadol's effects on serotonin and norepinephrine mimic the effects of other SNRI antidepressants such as duloxetine and venlafaxine.

Tramadol exists as a racemic mixture consisting of two pharmacologically active enantiomers that both contribute to its analgesic property through different mechanisms and are also themselves metabolized into active metabolites: (+)-tramadol and its primary metabolite (+)-O-desmethyl-tramadol (M1) are agonists of the μ opioid receptor while (+)-tramadol inhibits serotonin reuptake and (-)-tramadol inhibits norepinephrine reuptake. These pathways are complementary and synergistic, improving tramadol's ability to modulate the perception of and response to pain.

Tramadol has also been shown to affect a number of other pain modulators within the central nervous system as well as non-neuronal inflammatory markers and immune mediators. Due to the broad spectrum of targets involved in pain and inflammation, it's not surprising that the evidence has shown that tramadol is effective for a number of pain types including neuropathic pain, post-operative pain, lower back pain, as well as pain associated with labour, osteoarthritis, fibromyalgia, and cancer. Due to its SNRI activity, tramadol also has anxiolytic, antidepressant, and anti-shivering effects which are all frequently found as comorbidities with pain.

Similar to other opioid medications, tramadol poses a risk for development of tolerance, dependence and abuse. If used in higher doses, or with other opioids, there is a dose-related risk of overdose, respiratory depression, and death. However, unlike other opioid medications, tramadol use also carries a risk of seizure and serotonin syndrome, particularly if used with other serotonergic medications.

Indication

Tramadol is approved for the management of moderate to severe pain in adults.

Tramadol is also used off-label in the treatment of premature ejaculation.

Associated Conditions
Acute Pain, Premature Ejaculation, Severe Pain, Acute, moderate, severe Pain, Moderate Pain
Associated Therapies
-

Postoperative Tramadol/Gabapentin/Ibuprofen Versus Tramadol/Placebo/Ibuprofen

First Posted Date
2014-03-04
Last Posted Date
2017-02-09
Lead Sponsor
Children's Hospitals and Clinics of Minnesota
Target Recruit Count
64
Registration Number
NCT02076893
Locations
🇺🇸

Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States

Tramadol Versus Celecoxib for Reducing Pain in Outpatient Hysteroscopy

Phase 2
Completed
Conditions
Interventions
First Posted Date
2014-02-25
Last Posted Date
2015-01-05
Lead Sponsor
Cairo University
Target Recruit Count
210
Registration Number
NCT02071303
Locations
🇪🇬

Cairo University Hospitals, Cairo, Egypt

Evaluation of the Role of Tramadol 50mg as an Analgesic During Outpatient Hysteroscopy

Phase 2
Completed
Conditions
Interventions
First Posted Date
2014-02-21
Last Posted Date
2015-04-06
Lead Sponsor
Cairo University
Target Recruit Count
140
Registration Number
NCT02068209
Locations
🇪🇬

Cairo University Hospitals, Cairo, Egypt

Tamadol Wound Infiltration in Children Under Inguinal Hernioplasty

Phase 4
Completed
Conditions
Interventions
First Posted Date
2013-09-17
Last Posted Date
2013-09-17
Lead Sponsor
Federal University of São Paulo
Target Recruit Count
40
Registration Number
NCT01943760
Locations
🇧🇷

São Paulo Hospital, São Paulo, Brazil

Tramadol for Labour Analgesia in Low Risk Primiparous Women

Phase 3
Completed
Conditions
Interventions
First Posted Date
2013-07-01
Last Posted Date
2013-07-09
Lead Sponsor
Saint Thomas Hospital, Panama
Target Recruit Count
100
Registration Number
NCT01889979
Locations
🇵🇦

Saint Thomas Maternity Hospital, Panama, Panama

DPNB for Prevention of CRDB

First Posted Date
2012-11-02
Last Posted Date
2018-09-17
Lead Sponsor
West China Hospital
Target Recruit Count
58
Registration Number
NCT01721031
Locations
🇨🇳

West China Hospital, Sichuan University, Chengdu, Sichuan, China

Combined Behavioral and Analgesic Trial for Fibromyalgia

First Posted Date
2012-05-15
Last Posted Date
2019-06-26
Lead Sponsor
University of Washington
Target Recruit Count
134
Registration Number
NCT01598753
Locations
🇺🇸

University of Rochester, Rochester, New York, United States

🇺🇸

University of Washington, Seattle, Washington, United States

Perioperative Electroacupuncture on Postoperative Analgesia in Prostatectomy

First Posted Date
2012-02-06
Last Posted Date
2014-02-21
Lead Sponsor
G.Gennimatas General Hospital
Target Recruit Count
70
Registration Number
NCT01526525
Locations
🇬🇷

G.Gennimatas GENERAL HOSPITAL OF THESSALONIKI, Thessaloniki, Greece

Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD)

Phase 4
Completed
Conditions
Interventions
First Posted Date
2012-01-25
Last Posted Date
2022-08-31
Lead Sponsor
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
Target Recruit Count
40
Registration Number
NCT01517711
Locations
🇺🇸

Cincinnati VA Medical Center, Cincinnati, Ohio, United States

© Copyright 2024. All Rights Reserved by MedPath